EFFICIENCY OF COMBINATION THERAPY WITH ROSUVASTATIN FOR ACUTE CORONARY SYNDROME AND IN THE INFARCTION PERIOD

Download full text PDF
Issue: 
12
Year: 
2015

S. Islamova; Professor G. Babushkina, MD City Clinical Hospital Thirteen, Ufa

The paper shows the efficiency of using different rosuvastatin doses in the combination therapy of patients with acute coronary syndrome and in the postinfarction period according to lipidogram readings and intracardiac hemodynamic parameters.

Keywords: 
acute myocardial infarction
acute coronary syndrome
rosuvastatin
postinfarction period
intracardiac hemodynamic parameters
lipidogram



It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Rojtberg G.E., Strutynskij A.V. Vnutrennie bolezni. Serdechno- sosudistaja sistema: ucheb. posobie. 3-e izdanie / M.: MEDpress-inform, 2013; s. 495.
  2. Dzhaiani N.A. Primenenie statinov pri ostrom koronarnom sindrome. Pozitsii rozuvastatina // Rus. med. zhurn. – 2014; 18: 1345–8.
  3. Hamm C., Bassand J., Agewall S. et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC) // Eur. Heart J. – 2011; 32: 2999–3054.
  4. Erbs S., Beck E., Linke A. et al. High-dose rosuvastatin in chronic heart failure promotes vas-culogenesis, corrects endothelial function, and improves cardiac remodeling-results from a randomized, double-blind, and placebo-controlled study // Int. J. Cardiol. – 2011; 146 (1): 58–63.
  5. Pitt B., Loscalzo J., Monyak J. et al. Comparison of Lipid-Modifying Efficacy of Rosuvastatin Versus Atorvastatin in Patient With Acute Coronary Syndrome (from the LUNAR) // Am. J. Cardiol. – 2012; 109 (9): 1239–46.